Treatment of toxic epidermal necrolysis syndrome with "disease-modifying" drugs: the controversy goes on.
Wolf
Ronni
R
Dermatology Unit, Kaplan Medical Center, Rechovot, Israel. wolf_r@netvision.net.il
Ruocco
Vincenzo
V
Jablonska
Stefania
S
D002053:Burn Units; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000628:therapy*
D007155:Immunologic Factors; D013256:Steroids